Stocks360

Bullfrog AI Holdings, Inc. Common Stock (BFRG)

Stock analysis · NASDAQ · Healthcare · Medical - Healthcare Information Services

Share: Facebook X WhatsApp SMS
$0.49

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$9.03M
PE (TTM)
-1.04
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
-2.74
Day Range
$0.46 – $0.50
52-wk Range
$0.43 – $1.96
Avg Volume
N/A
Volume
93.66K

Bullfrog AI Holdings, Inc. Common Stock (BFRG) is a publicly traded company in the Healthcare sector. Latest price: $0.49. Market cap $9.03M. Trailing PE -1.04. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $1.31 2026-10-28 · $0.49 (-62.82%)

Earnings

Most Recent
Aug 14, 2026
EPS $-0.07 vs est. $-0.07
Beat by $0.00
Next Earnings
Nov 13, 2026
EPS estimate $-0.09

Proprietary Signals

Signal snapshot temporarily unavailable.

About Bullfrog AI Holdings, Inc. Common Stock

BullFrog AI Holdings, Inc., along with its affiliated entities, functions as an advanced digital biopharmaceutical firm. Its core mission involves harnessing artificial intelligence and machine learning (AI/ML) to process and interpret extensive medical and healthcare datasets specifically within the United States. A central offering is bfLEAP, a proprietary AI/ML platform meticulously crafted for the thorough examination of both preclinical and clinical research data. The company has also secured critical intellectual property through licensing agreements. One such accord, with George Washington University, provides rights to utilize siRNA targeting Beta2-spectrin. This technology is being investigated for its therapeutic potential across a spectrum of human conditions, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). Additionally, a partnership with Johns Hopkins University grants access to a distinct Mebendazole formulation, developed for the treatment of various human cancers or neoplastic diseases. Founded in 2017, BullFrog AI Holdings, Inc. operates from its headquarters in Gaithersburg, Marylan…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-1.04×
P/S (TTM)30.23×
P/B1.31×
P/FCF (TTM)-1.64×
EV / EBITDA-0.37×
EV / Sales7.37×
Earnings Yield-65.45%
Free Cash Flow Yield-60.89%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$2.20M
Revenue (TTM)$298.80K
Net Income (TTM)-$5.91M
Free Cash Flow (TTM)-$5.49M
Net Debt-$6.83M
Working Capital$6.76M
Gross Margin40.92%
Operating Margin-2042.19%
Net Margin-2006.87%
Return on Equity-150.34%
Return on Invested Capital-86.22%

Peers

Recent News

Related

Browse more tickers: sitemap